December 01, 2022
insitro
insitro Appoints Philip Tagari, Industry-Leading Scientist and Drug Hunter, as Chief Scientific Officer
November 15, 2022
Casma Therapeutics
Casma Therapeutics Raises $46.0 M in Series C Funding
November 10, 2022
Asher Bio
Asher Bio Presents New Preclinical Data at SITC 2022 Further Supporting Advancement of AB248 and AB821 as Highly Differentiated Cis-targeted Cancer Immunotherapies
November 10, 2022
Tango Therapeutics
Tango Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Highlights
November 09, 2022
Decibel Therapeutics
Decibel Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Update